News | February 22, 2025
Aster DM Healthcare to invest Rs. 850 crore in next 3 years in Kerala
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Wockhardt also saw its revenue from operations increased 3% to Rs. 721 crore during Q3 FY25
EBITDA margins expand to 31.3%
The approved product has an estimated market size of US$ 106 million for the twelve months ending October 2024, according to IQVIA
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
The 254-bedded Aster Aadhar Hospital, Kolhapur is the city's most comprehensive multi-speciality hospital
The product is expected to be launched in Q3FY25
The company is making its mark through strategic initiatives, promising to become a significant presence in the evolving pharmaceutical sector
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Subscribe To Our Newsletter & Stay Updated
